Dr. Irbaz Bin Riaz, MD, MS

Dr. Riaz practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Riaz's NPI, 1033460316, was assigned on September 26, 2012. Dr. Riaz holds Arizona license 50467.

Dr. Riaz's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Riaz's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Riaz is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Riaz to 2 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Riaz's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Riaz practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Riaz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Riaz's licenses on file in 2 states: Arizona and Minnesota.

CMS data shows 29,932 Medicare services from Dr. Riaz across 41 procedure codes in 2024, for 561 Medicare patients. Medicare paid $629,954 for them. Every service was in an office.

CMS counts 561 Medicare patients who saw Dr. Riaz in 2024. The largest group is 65 to 74, with 270 patients. 74% of them have high blood pressure, and 69% have high cholesterol. 3% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Riaz's median patient age at 72, with 42% women.

In 2024, Dr. Riaz wrote 411 Medicare Part D claims for 62 patients. 67% of them were for generic drugs. CMS names the drug for 298 of them, across 10 drugs with 11 or more claims each, at $1,666,612 in total drug cost. In 2020, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Riaz for performance year 2024, reported as part of a group. Dr. Riaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Riaz as offering telehealth.

Dmand AI links 140 papers to Dr. Riaz, published from 2012 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Randomized Controlled Trials as Topic, Prostatic Neoplasms and Cardiovascular Diseases. Dr. Riaz has published most often in Am J Med. Dr. Riaz's most frequent co-authors are Mohammad Hassan Murad, MD, Alan Haruo Bryce, MD and Jawad Bilal, MD.

CMS Open Payments shows 26 general payments to Dr. Riaz from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Eisai Inc. paid the most, $2,850.